Nebracetam

The topic of this article may not meet Wikipedia's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (May 2015) (Learn how and when to remove this template message)

This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help by introducing citations to additional sources. Find sources:  –  ·  ·  · scholar · JSTOR (June 2015)

Nebracetam

Clinical data
ATC code	none
Legal status
Legal status	AU: S4 (Prescription only) US: Unscheduled Not FDA approved
Identifiers
IUPAC name (RS)-4-(Aminomethyl)-1-benzylpyrrolidin-2-one
CAS Number	97205-34-0 Y
PubChem CID	65926
ChemSpider	59334 Y
UNII	T30038QI8N
ChEMBL	ChEMBL2104682 N
Chemical and physical data
Formula	C12H16N2O
Molar mass	204.273 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES O=C2N(Cc1ccccc1)CC(C2)CN
InChI InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 Y Key:LCAFGJGYCUMTGS-UHFFFAOYSA-N Y
NY (what is this?)

Nebracetam is an investigational drug of the racetam family that is a M₁ acetylcholine receptor agonist in rats.^[1] Its effects in humans have not been studied.

See also[]

• Piracetam
• Aniracetam
• Racetam

References[]

This drug article relating to the nervous system is a stub. You can help Wikipedia by .

• v
• t